Bart Endrizzi
MOHS-Micrographic Surgery · Fridley, MNNPI 1235323585
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations.
Across 44 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$97
- Sun Pharmaceutical Industries Inc.$66
- Sanofi$65
- AbbVie$51
- Genentech USA, Inc.$47
- UCB, Inc.$46
- plus $390 from 16 others
What the payments were for
- Food & beverage$762100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 6 | $97 |
| Sun Pharmaceutical Industries Inc. | 4 | $66 |
| Sanofi | 4 | $65 |
| AbbVie | 2 | $51 |
| Genentech USA, Inc. | 2 | $47 |
| UCB, Inc. | 3 | $46 |
| LEO Pharma Inc. | 3 | $44 |
| Biofrontera Inc. | 2 | $38 |
| Mylan Institutional Inc. | 2 | $38 |
| Mimedx Group, Inc. | 1 | $34 |
| Lilly USA, LLC | 2 | $33 |
| Novartis | 2 | $32 |
| Incyte Corporation | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Botanix SB Inc | 1 | $19 |
| Dermavant Sciences, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $15 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Kerecis Limited | 1 | $14 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $13 |
| Amgen | 1 | $13 |
How this compares
$762 in reported general payments places this provider in the 75th percentile of 29 mohs-micrographic surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 66 | $4,416 |
| Mupirocin | 184 | $1,453 |
| Cephalexin | 91 | $481 |
| Triamcinolone Acetonide | 30 | $406 |
| Minocycline Hcl | 33 | $212 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $65 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $52 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Fridley
- Frederick FishFridley$427
- Ian MaherMinneapolis$18K
- Laura RezacRoseville$15K
- Edward SegerPlymouth$4K
- Addison DemerRochester$4K
- Anna-Bianca StashakRochester$902
- Ryan LaddRochester$808
- Elliott CampbellRochester$732
- Chandler RundleMinneapolis$652
- Julie CronkSaint Paul$523
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.